Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Jul 21, 2023

BUY
$118.5 - $160.53 $11,850 - $16,053
100 New
100 $12,000
Q3 2022

Nov 03, 2022

BUY
$118.07 - $194.18 $47,228 - $77,672
400 New
400 $13,000
Q1 2021

Apr 30, 2021

SELL
$109.18 - $185.98 $87,344 - $148,784
-800 Reduced 80.0%
200 $1,000
Q3 2020

Nov 05, 2020

BUY
$54.34 - $94.85 $21,736 - $37,940
400 Added 66.67%
1,000 $4,000
Q2 2020

Jul 23, 2020

BUY
$29.67 - $80.0 $17,802 - $48,000
600 New
600 $2,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.